BHAT LAXMINARAYAN enters REVIVA PHARMACEUTICALS HOLDINGS, INC. with 2.48M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 12/18/2020ACC: 0001104659-20-137397
DirectorOfficer10% Owner· President and CEO
Since Dec 2020
2.48M
Baseline shares
100% direct
2.48M
Direct ownership
1 position
6.09K
Derivative underlying
1 instrument
2
Security positions
5.39K indirect
Non-Derivative Holdings2
Common Stock
DirectShares owned2.48M
Common Stock
IndirectShares owned5.39K
Total
2.48M direct·5.39K indirect2.48M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.48M | Direct |
| Common Stock | 5.39K | Indirect |
| Total | 2.48M | 2.48M direct·5.39K indirect |
Derivative Holdings1
Stock Option
IndirectUnderlying security
Common Stock
Underlying shares
6.09K
Shares owned
N/A
Exercise price
31.33
Expiration
—
Exercise window
—
Total
Underlying
6.09K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option Indirect | Common Stock | 31.33 | — | — | 6.09K | N/A |
| Total | 6.09K | 0.00 | ||||